Titre : 5-Méthyl-cytosine

5-Méthyl-cytosine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "5-Méthyl-cytosine : Questions médicales les plus fréquentes", "headline": "5-Méthyl-cytosine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les 5-Méthyl-cytosine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "5-Méthyl-cytosine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cytosine", "url": "https://questionsmedicales.fr/mesh/D003596", "about": { "@type": "MedicalCondition", "name": "Cytosine", "code": { "@type": "MedicalCode", "code": "D003596", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.742.698.421" } } }, "about": { "@type": "MedicalCondition", "name": "5-Méthyl-cytosine", "alternateName": "5-Methylcytosine", "code": { "@type": "MedicalCode", "code": "D044503", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Yun-Gui Yang", "url": "https://questionsmedicales.fr/author/Yun-Gui%20Yang", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Genomic and Precision Medicine, Collaborative Innovation Center of Genetics and Development, College of Future Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China; Sino-Danish College, University of Chinese Academy of Sciences, Beijing 101408, China; Institute of Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing 100101, China. Electronic address: ygyang@big.ac.cn." } }, { "@type": "Person", "name": "Ying Yang", "url": "https://questionsmedicales.fr/author/Ying%20Yang", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Genomic and Precision Medicine, College of Futuer Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China." } }, { "@type": "Person", "name": "Qing Dai", "url": "https://questionsmedicales.fr/author/Qing%20Dai", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Chicago, Chicago, IL 60637." } }, { "@type": "Person", "name": "Chuan He", "url": "https://questionsmedicales.fr/author/Chuan%20He", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, The University of Chicago, Chicago, IL 60637." } }, { "@type": "Person", "name": "Bao-Fa Sun", "url": "https://questionsmedicales.fr/author/Bao-Fa%20Sun", "affiliation": { "@type": "Organization", "name": "CAS Key Laboratory of Genomic and Precision Medicine, College of Futuer Technology, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project.", "datePublished": "2023-06-14", "url": "https://questionsmedicales.fr/article/37854782", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/flgastro-2023-102423" } }, { "@type": "ScholarlyArticle", "name": "Old age takes its toll: Long-run projections of health-related public expenditure in Luxembourg.", "datePublished": "2023-06-03", "url": "https://questionsmedicales.fr/article/37311273", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ehb.2023.101262" } }, { "@type": "ScholarlyArticle", "name": "EPA Consensus Project Paper: The Vertical Dimension of Occlusion. How to Determine and How to Alter? A Systematic Review.", "datePublished": "2023-06-01", "url": "https://questionsmedicales.fr/article/37265247", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1922/EJPRD_2487Pissiotis13" } }, { "@type": "ScholarlyArticle", "name": "Construction of semi-supervised spatial projections to identify the source of beta- and high frequency oscillations in Parkinson's disease.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37601420", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1109/ner52421.2023.10123890" } }, { "@type": "ScholarlyArticle", "name": "Characterization of PDMS Microchannels Using Horizontally or Vertically Formed 3D-Printed Molds by Digital Light Projection.", "datePublished": "2023-05-18", "url": "https://questionsmedicales.fr/article/37273587", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acsomega.3c02933" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétéromonocycliques", "item": "https://questionsmedicales.fr/mesh/D006573" }, { "@type": "ListItem", "position": 4, "name": "Pyrimidines", "item": "https://questionsmedicales.fr/mesh/D011743" }, { "@type": "ListItem", "position": 5, "name": "Pyrimidinones", "item": "https://questionsmedicales.fr/mesh/D011744" }, { "@type": "ListItem", "position": 6, "name": "Cytosine", "item": "https://questionsmedicales.fr/mesh/D003596" }, { "@type": "ListItem", "position": 7, "name": "5-Méthyl-cytosine", "item": "https://questionsmedicales.fr/mesh/D044503" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : 5-Méthyl-cytosine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur 5-Méthyl-cytosine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur 5-Méthyl-cytosine", "description": "Comment détecte-t-on la 5-méthylcytosine ?\nQuels tests sont utilisés pour évaluer la méthylation ?\nLa 5-méthylcytosine est-elle mesurable dans le sang ?\nQuels biomarqueurs sont associés à la 5-méthylcytosine ?\nLa 5-méthylcytosine est-elle liée à des maladies ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Pilot+Projects&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur 5-Méthyl-cytosine", "description": "Quels symptômes sont liés à la méthylation anormale ?\nLa 5-méthylcytosine affecte-t-elle le comportement ?\nY a-t-il des signes cliniques de dysfonctionnement ?\nLa 5-méthylcytosine est-elle liée à des symptômes neurologiques ?\nPeut-on observer des symptômes cutanés ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Pilot+Projects&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur 5-Méthyl-cytosine", "description": "Comment prévenir les anomalies de méthylation ?\nLe stress influence-t-il la méthylation ?\nLes suppléments nutritionnels aident-ils ?\nL'exercice physique a-t-il un impact ?\nLes habitudes de sommeil affectent-elles la méthylation ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Pilot+Projects&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur 5-Méthyl-cytosine", "description": "Quels traitements ciblent la méthylation ?\nLa thérapie génique peut-elle corriger la méthylation ?\nY a-t-il des traitements préventifs ?\nLes médicaments peuvent-ils influencer la méthylation ?\nComment la recherche avance-t-elle sur ce sujet ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Pilot+Projects&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur 5-Méthyl-cytosine", "description": "Quelles complications sont liées à la méthylation anormale ?\nLa 5-méthylcytosine est-elle liée à des troubles mentaux ?\nY a-t-il des risques de maladies cardiovasculaires ?\nLes complications peuvent-elles être réversibles ?\nLa 5-méthylcytosine affecte-t-elle la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Pilot+Projects&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur 5-Méthyl-cytosine", "description": "Quels facteurs augmentent le risque de méthylation anormale ?\nLe tabagisme influence-t-il la méthylation ?\nL'environnement joue-t-il un rôle ?\nLes antécédents familiaux influencent-ils le risque ?\nLe mode de vie a-t-il un impact sur la méthylation ?", "url": "https://questionsmedicales.fr/mesh/D044503?mesh_terms=Pilot+Projects&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on la 5-méthylcytosine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "La détection se fait par des techniques comme la bisulfite séquençage." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la méthylation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme le PCR en temps réel et le séquençage de nouvelle génération sont utilisés." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle mesurable dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des échantillons sanguins peuvent être analysés pour la méthylation de l'ADN." } }, { "@type": "Question", "name": "Quels biomarqueurs sont associés à la 5-méthylcytosine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des biomarqueurs comme les gènes régulés par la méthylation peuvent être identifiés." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle liée à des maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est associée à des maladies comme le cancer et des troubles neurologiques." } }, { "@type": "Question", "name": "Quels symptômes sont liés à la méthylation anormale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes peuvent inclure des troubles cognitifs et des anomalies de développement." } }, { "@type": "Question", "name": "La 5-méthylcytosine affecte-t-elle le comportement ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des modifications de la méthylation peuvent influencer le comportement et l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des signes cliniques de dysfonctionnement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes peuvent inclure des troubles métaboliques et des problèmes immunitaires." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle liée à des symptômes neurologiques ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est impliquée dans des maladies neurodégénératives et des troubles psychiatriques." } }, { "@type": "Question", "name": "Peut-on observer des symptômes cutanés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies cutanées peuvent survenir en raison de troubles liés à la méthylation." } }, { "@type": "Question", "name": "Comment prévenir les anomalies de méthylation ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent réduire les risques." } }, { "@type": "Question", "name": "Le stress influence-t-il la méthylation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter les niveaux de méthylation de l'ADN." } }, { "@type": "Question", "name": "Les suppléments nutritionnels aident-ils ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme l'acide folique, peuvent soutenir une méthylation saine." } }, { "@type": "Question", "name": "L'exercice physique a-t-il un impact ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut influencer positivement la méthylation de l'ADN." } }, { "@type": "Question", "name": "Les habitudes de sommeil affectent-elles la méthylation ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un sommeil de qualité est crucial pour maintenir une méthylation adéquate." } }, { "@type": "Question", "name": "Quels traitements ciblent la méthylation ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des agents déméthylants comme l'azacitidine sont utilisés pour traiter certains cancers." } }, { "@type": "Question", "name": "La thérapie génique peut-elle corriger la méthylation ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique vise à restaurer la méthylation normale dans certaines conditions." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions diététiques et des modifications du mode de vie peuvent aider à prévenir des anomalies." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils influencer la méthylation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent modifier les niveaux de méthylation de l'ADN." } }, { "@type": "Question", "name": "Comment la recherche avance-t-elle sur ce sujet ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des études cliniques explorent de nouvelles thérapies ciblant la méthylation pour diverses maladies." } }, { "@type": "Question", "name": "Quelles complications sont liées à la méthylation anormale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent le développement de cancers et de maladies auto-immunes." } }, { "@type": "Question", "name": "La 5-méthylcytosine est-elle liée à des troubles mentaux ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies de méthylation peuvent contribuer à des troubles mentaux comme la dépression." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies cardiovasculaires ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien entre la méthylation et les maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les complications peuvent-elles être réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être atténuées par des traitements ciblés et des changements de mode de vie." } }, { "@type": "Question", "name": "La 5-méthylcytosine affecte-t-elle la fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des modifications de méthylation peuvent influencer la fertilité et le développement embryonnaire." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de méthylation anormale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'âge, l'alimentation et l'exposition à des toxines peuvent augmenter le risque." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la méthylation ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à des modifications de la méthylation de l'ADN." } }, { "@type": "Question", "name": "L'environnement joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter la méthylation." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque de méthylation anormale." } }, { "@type": "Question", "name": "Le mode de vie a-t-il un impact sur la méthylation ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent affecter la méthylation." } } ] } ] }

Sources (10000 au total)

Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project.

Despite its association with poorer outcomes, opioid use in inflammatory bowel disease (IBD) is not well characterised in the UK. We aimed to examine the extent of opioid use, the associated factors a... Data were collected from consecutive patients attending IBD outpatient appointments at 12 UK hospitals. A predefined questionnaire was used to collect data including patient demographics, IBD history,... In 1352 outpatients, 12% had used opioids within the past 12 months. Over half of these individuals were taking opioids for non-IBD pain and less than half had undergone an attempted opioid wean.In 32... 1 in 10 patients with IBD attending outpatient appointments were opioid exposed in the past year while a quarter of inpatients were discharged with opioids, and 11% continued to use opioids 12 months ...

EPA Consensus Project Paper: The Vertical Dimension of Occlusion. How to Determine and How to Alter? A Systematic Review.

The aim of this systematic review was to explore the dental literature to identify high quality clinical studies that introduced methods of determining the vertical dimension of occlusion (VDO), and a... An electronic search of the literature was conducted through PubMed , Embase, and Cochrane Library databases referring to the determination and alteration of the VDO by 12/2021.... A total of 215 records were obtained from the initial search. After the first two screenings, 33 studies were selected for inclusion. Correlations in the morphometric group ranged between r=0.18-0.87,... No clear guidelines can be established yet, in relation to the determination and alteration of the VDO. There is no apparent benefit in using more invasive and complex methods compared to the use of t...

Dynamics and consequences of nutrition-related microbial dysbiosis in early life: study protocol of the VITERBI GUT project.

Early life under- and overnutrition (jointly termed malnutrition) is increasingly recognized as an important risk factor for adult obesity and metabolic syndrome, a diet-related cluster of conditions ... VITERBI GUT is a prospective birth cohort allowing to study the link between early life malnutrition, the microbiota and metabolic health. VITERBI GUT will include 100 undernourished, 100 normally nou... We expect the VITERBI GUT project to contribute to the emerging literature linking the early life microbiota, epigenetic changes and growth/metabolic health. We also expect this project to give new (m...

Community partner perspectives on the implementation of a novel safer supply program in Canada: a qualitative study of the MySafe Project.

The adulteration of the illicit drug supply with fentanyl and its analogues is driving the ongoing overdose crisis in North America. While various harm reduction interventions address overdose-related... Semi-structured qualitative interviews were conducted with 17 professional community partners involved in program implementation across four pilot locations in Canada. Thematic analysis of interviews ... Participants identified a variety of barriers, including the dependence on clinician buy-in, coupled with regulatory and logistical constraints. In addition, some participants perceived hydromorphone ... To address the overdose crisis, there is an urgent need to implement and evaluate novel solutions that address supply drivers of crisis. Community partner-informed research plays an integral role in e...

Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.

The World Health Organization recommends changing the first-line antimicrobial treatment for gonorrhoea when ≥ 5% of Neisseria gonorrhoeae cases fail treatment or are resistant. Susceptibility to ceft... We used data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales from 2000-2018 about minimum inhibitory concentrations (MIC) for ciprofloxacin, azithr... The single-step model described resistance to ciprofloxacin well. Both single-step and multi-step models could describe azithromycin and cefixime resistance, with projected resistance levels higher wi... New first-line antimicrobials for gonorrhoea treatment are needed. In the meantime, public health authorities should strengthen surveillance for AMR in N. gonorrhoeae and implement strategies for cont...